GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for alkanesulfonate monooxygenase (B7LNV2)

Analyse AlphaFold monomer V2.0 prediction for alkanesulfonate monooxygenase (B7LNV2) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B7LNV2
Type
protein
Length
381 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xA340bF1534bceeae44fe12C7C9F6CF023b79E47e
Molecule
Alkanesulfonate monooxygenase
UniProt
B7LNV2
Pockets
2 · best druggability 0.79

Structure

1 distinct chain · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlkanesulfonate monooxygenaseprotein38141% helix, 18% strandB7LNV2

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17610.790.8367empty
2810.360.7619empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.